Compare GFS & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFS | MDLN |
|---|---|---|
| Founded | 2009 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.8B | 37.4B |
| IPO Year | 2017 | N/A |
| Metric | GFS | MDLN |
|---|---|---|
| Price | $57.67 | $39.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | $45.08 | ★ $50.48 |
| AVG Volume (30 Days) | 2.8M | ★ 7.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.64 | $10.88 |
| Revenue Next Year | $9.90 | $7.69 |
| P/E Ratio | ★ $29.28 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.51 | $32.82 |
| 52 Week High | $92.55 | $50.88 |
| Indicator | GFS | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 30.64 | 51.73 |
| Support Level | $40.24 | $38.50 |
| Resistance Level | $90.61 | $43.87 |
| Average True Range (ATR) | 4.01 | 1.58 |
| MACD | -1.98 | -0.08 |
| Stochastic Oscillator | 9.14 | 36.76 |
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.